nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0232	0.332	CbGbCtD
Esomeprazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0215	0.308	CbGbCtD
Esomeprazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00988	0.142	CbGbCtD
Esomeprazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00906	0.13	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00618	0.0885	CbGbCtD
Esomeprazole—Pantoprazole—ABCB1—peripheral nervous system neoplasm	0.00291	0.391	CrCbGaD
Esomeprazole—Omeprazole—ABCB1—peripheral nervous system neoplasm	0.00237	0.318	CrCbGaD
Esomeprazole—Lansoprazole—ABCB1—peripheral nervous system neoplasm	0.00217	0.291	CrCbGaD
Esomeprazole—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000331	CcSEcCtD
Esomeprazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000305	0.00033	CcSEcCtD
Esomeprazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.000329	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000327	CcSEcCtD
Esomeprazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000327	CcSEcCtD
Esomeprazole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000301	0.000326	CcSEcCtD
Esomeprazole—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000326	CcSEcCtD
Esomeprazole—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000325	CcSEcCtD
Esomeprazole—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000324	CcSEcCtD
Esomeprazole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000299	0.000324	CcSEcCtD
Esomeprazole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000298	0.000323	CcSEcCtD
Esomeprazole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000323	CcSEcCtD
Esomeprazole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000297	0.000322	CcSEcCtD
Esomeprazole—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000319	CcSEcCtD
Esomeprazole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000319	CcSEcCtD
Esomeprazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000294	0.000319	CcSEcCtD
Esomeprazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000318	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000316	CcSEcCtD
Esomeprazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000292	0.000316	CcSEcCtD
Esomeprazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000291	0.000316	CcSEcCtD
Esomeprazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000314	CcSEcCtD
Esomeprazole—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000314	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000289	0.000313	CcSEcCtD
Esomeprazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000289	0.000313	CcSEcCtD
Esomeprazole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000289	0.000313	CcSEcCtD
Esomeprazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000311	CcSEcCtD
Esomeprazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000311	CcSEcCtD
Esomeprazole—Pain—Etoposide—peripheral nervous system neoplasm	0.000287	0.00031	CcSEcCtD
Esomeprazole—Constipation—Etoposide—peripheral nervous system neoplasm	0.000287	0.00031	CcSEcCtD
Esomeprazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00031	CcSEcCtD
Esomeprazole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00031	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00031	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00031	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000308	CcSEcCtD
Esomeprazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.000308	CcSEcCtD
Esomeprazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000283	0.000307	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000306	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000304	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000302	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000302	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000301	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000301	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.0003	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000299	CcSEcCtD
Esomeprazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000276	0.000299	CcSEcCtD
Esomeprazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000275	0.000298	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000298	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000274	0.000297	CcSEcCtD
Esomeprazole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000273	0.000296	CcSEcCtD
Esomeprazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000273	0.000296	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000295	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000295	CcSEcCtD
Esomeprazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000293	CcSEcCtD
Esomeprazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.000293	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000293	CcSEcCtD
Esomeprazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000269	0.000292	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000292	CcSEcCtD
Esomeprazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.000291	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00029	CcSEcCtD
Esomeprazole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000266	0.000288	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000288	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000288	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000287	CcSEcCtD
Esomeprazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000265	0.000287	CcSEcCtD
Esomeprazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000265	0.000287	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000287	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000287	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000286	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000285	CcSEcCtD
Esomeprazole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000263	0.000285	CcSEcCtD
Esomeprazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000262	0.000284	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000284	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Esomeprazole—Rash—Vincristine—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Esomeprazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000261	0.000282	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000282	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000282	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000282	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000281	CcSEcCtD
Esomeprazole—Headache—Vincristine—peripheral nervous system neoplasm	0.000259	0.000281	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.000279	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000279	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000277	CcSEcCtD
Esomeprazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.000276	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000276	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000276	CcSEcCtD
Esomeprazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000271	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000271	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00027	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000268	CcSEcCtD
Esomeprazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000247	0.000268	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000267	CcSEcCtD
Esomeprazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000246	0.000266	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000266	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000266	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000265	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000264	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000263	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000262	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000261	CcSEcCtD
Esomeprazole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00024	0.000261	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00026	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00026	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000259	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000258	CcSEcCtD
Esomeprazole—Chills—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000257	CcSEcCtD
Esomeprazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000237	0.000257	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000255	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000253	CcSEcCtD
Esomeprazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000233	0.000252	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000251	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000251	CcSEcCtD
Esomeprazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00025	CcSEcCtD
Esomeprazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00023	0.00025	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000249	CcSEcCtD
Esomeprazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000229	0.000248	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000248	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000247	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000246	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000246	CcSEcCtD
Esomeprazole—Tension—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000245	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000244	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000242	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000241	CcSEcCtD
Esomeprazole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000222	0.00024	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00024	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000239	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000239	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000238	CcSEcCtD
Esomeprazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000217	0.000235	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000235	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000234	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000232	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000231	CcSEcCtD
Esomeprazole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000213	0.000231	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000231	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000213	0.00023	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000229	CcSEcCtD
Esomeprazole—Rash—Etoposide—peripheral nervous system neoplasm	0.000211	0.000229	CcSEcCtD
Esomeprazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000211	0.000229	CcSEcCtD
Esomeprazole—Headache—Etoposide—peripheral nervous system neoplasm	0.00021	0.000227	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000227	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000226	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000226	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000225	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000224	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000224	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000223	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000223	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000222	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000203	0.00022	CcSEcCtD
Esomeprazole—Cough—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000218	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000217	CcSEcCtD
Esomeprazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000199	0.000216	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000215	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000214	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000213	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000212	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000212	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000211	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00021	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000208	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000208	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000207	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000207	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000205	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000204	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000204	CcSEcCtD
Esomeprazole—Infection—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000202	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000201	CcSEcCtD
Esomeprazole—Shock—Epirubicin—peripheral nervous system neoplasm	0.000185	0.0002	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000184	0.0002	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000199	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000199	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000199	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000198	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000197	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000196	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000195	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000194	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000194	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000192	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.00019	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000188	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000187	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000185	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000185	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000185	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000184	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000184	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000184	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000183	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000183	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000182	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000181	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000181	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00018	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000179	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000177	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000176	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000175	CcSEcCtD
Esomeprazole—Pain—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000174	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000174	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000172	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.00017	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000169	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000168	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000168	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000167	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000166	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000166	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000163	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000162	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000162	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000161	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000161	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000155	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000154	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000138	0.00015	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00015	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000146	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000144	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000139	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000139	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000135	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000135	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000133	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000129	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000129	CcSEcCtD
Esomeprazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000128	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000128	CcSEcCtD
Esomeprazole—Headache—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000128	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000125	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000121	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00012	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000119	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000119	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000118	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000112	CcSEcCtD
